To highlight a rare but clinically relevant complication of immune checkpoint inhibitor (ICI) use in a breast cancer patient with new-onset refractory status epilepticus (NORSE).
No takes yet. Share an insight, caveat, or question.
Whitham et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: